TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing long-lived plasma cells in the bone marrow by Shoichiro Tsuji, Catarina Cortesão,

Slides:



Advertisements
Similar presentations
Volume 40, Issue 4, Pages (April 2014)
Advertisements

by Benjamin J. Frisch, John M. Ashton, Lianping Xing, Michael W
by Leah J. Anderson, and Richard Longnecker
Defects in T-cell–mediated immunity to influenza virus in murine Wiskott-Aldrich syndrome are corrected by oncoretroviral vector–mediated gene transfer.
Th9 Cells Drive Host Immunity against Gastrointestinal Worm Infection
by Rong L. He, Jian Zhou, Crystal Z
Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer by Ou Cao, Eric Dobrzynski,
by Silke Huber, Reinhard Hoffmann, Femke Muskens, and David Voehringer
Ting-ting Zhang, MSc, Klaus Okkenhaug, PhD, Baher F
Novel function for interleukin-7 in dendritic cell development
Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells by Wuding Zhou, Hetal Patel, Ke Li, Qi Peng, Marie-Bernadette.
Ikaros is required for plasmacytoid dendritic cell differentiation
Volume 31, Issue 2, Pages (August 2009)
Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic.
Simple conditioning with monospecific CD4+CD25+ regulatory T cells for bone marrow engraftment and tolerance to multiple gene products by David-Alexandre.
Volume 14, Issue 1, Pages (January 2016)
Silvia Bolland, Jeffrey V Ravetch  Immunity 
by Feng Guo, Debra Weih, Elke Meier, and Falk Weih
Volume 11, Issue 12, Pages (June 2015)
Mst1 positively regulates B-cell receptor signaling via CD19 transcriptional levels by Xiaoming Bai, Lu Huang, Linlin Niu, Yongjie Zhang, Jinzhi Wang,
Volume 23, Issue 11, Pages (June 2018)
Macrophages prevent the differentiation of autoreactive B cells by secreting CD40 ligand and interleukin-6 by Michelle A. Kilmon, Nikki J. Wagner, Alaina.
The DNA-Mismatch Repair Enzyme hMSH2 Modulates UV-B-Induced Cell Cycle Arrest and Apoptosis in Melanoma Cells  Markus Seifert, Stefan J. Scherer, Wilfried.
Volume 29, Issue 6, Pages (December 2008)
Soluble PD-1 ligands regulate T-cell function in Waldenstrom macroglobulinemia by Shahrzad Jalali, Tammy Price-Troska, Jonas Paludo, Jose Villasboas, Hyo-Jin.
Volume 18, Issue 5, Pages (May 2003)
Zhiwen He, Julie O'Neal, William C
Balthazar B Cazac, Jürgen Roes  Immunity 
Volume 19, Issue 2, Pages (August 2003)
Volume 24, Issue 3, Pages (March 2006)
James I Kim, I-Cheng Ho, Michael J Grusby, Laurie H Glimcher  Immunity 
B-1a and B-1b Cells Exhibit Distinct Developmental Requirements and Have Unique Functional Roles in Innate and Adaptive Immunity to S. pneumoniae  Karen.
Takao Kobayashi, PhD, Koji Iijima, PhD, Alexander L
Volume 40, Issue 4, Pages (April 2014)
Volume 19, Issue 4, Pages (October 2003)
Humoral Immunity Due to Long-Lived Plasma Cells
by Kalpana Parvathaneni, and David W. Scott
Volume 22, Issue 3, Pages (March 2005)
Novel Role of the Ras Cascade in Memory B Cell Response
Myeloma cell–derived Runx2 promotes myeloma progression in bone
Volume 23, Issue 4, Pages (October 2005)
Volume 27, Issue 3, Pages (September 2007)
Volume 25, Issue 2, Pages (August 2006)
Volume 16, Issue 2, Pages (February 2002)
Volume 29, Issue 1, Pages (July 2008)
Natural IgE Production in the Absence of MHC Class II Cognate Help
Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8+ T Cells and Memory Responses  Axel Kallies, Annie Xin, Gabrielle T.
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Homeostasis of dendritic cells in lymphoid organs is controlled by regulation of their precursors via a feedback loop by Kristin Hochweller, Tewfik Miloud,
Francis Coffey, Boris Alabyev, Tim Manser  Immunity 
Volume 37, Issue 5, Pages (November 2012)
T Cell–Mediated Elimination of B7.2 Transgenic B Cells
Volume 119, Issue 1, Pages (July 2000)
Volume 29, Issue 1, Pages (July 2008)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Volume 37, Issue 5, Pages (November 2012)
Sibylle von Vietinghoff, Hui Ouyang, Klaus Ley  Kidney International 
Volume 11, Issue 3, Pages (September 1999)
Volume 13, Issue 6, Pages (November 2015)
Volume 25, Issue 12, Pages e5 (December 2018)
Volume 30, Issue 5, Pages (May 2009)
Volume 31, Issue 6, Pages (December 2009)
Volume 9, Issue 5, Pages (November 1998)
Volume 28, Issue 5, Pages (May 2008)
Volume 31, Issue 5, Pages (November 2009)
Volume 33, Issue 1, Pages (July 2010)
by Gonghua Huang, Yanyan Wang, Peter Vogel, and Hongbo Chi
Repulsive Guidance Molecule-a Is Involved in Th17-Cell-Induced Neurodegeneration in Autoimmune Encephalomyelitis  Shogo Tanabe, Toshihide Yamashita  Cell.
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Volume 10, Issue 3, Pages (March 1999)
Presentation transcript:

TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing long-lived plasma cells in the bone marrow by Shoichiro Tsuji, Catarina Cortesão, Richard J. Bram, Jeffrey L. Platt, and Marilia Cascalho Blood Volume 118(22):5832-5839 November 24, 2011 ©2011 by American Society of Hematology

TACI deficiency decreased serum IgM, IgG, and IgA and impaired antigen-specific IgM production in response to a protein antigen. TACI deficiency decreased serum IgM, IgG, and IgA and impaired antigen-specific IgM production in response to a protein antigen. (A) Sera IgM, IgG1, IgG3, IgG2b, and IgA quantified by ELISA. Sera were obtained from nonimmunized C57BL/6-TACI-wt (TACI-wt) or C57BL/6-TACI-ko (TACI-ko) mice. Concentrations were calculated by comparison with standard curves obtained with known concentrations of the respective isotypes. (B-C) Concentrations of NP-specific IgM (B) or IgG (C) determined by ELISA in the sera of C57BL/6-TACI-wt (TACI-wt) or C57BL/6-TACI-ko (TACI-ko) mice immunized with 100 μg NP-OVA 21 days earlier. TACI deficiency decreased NP-specific IgM but not NP-specific IgG. Concentrations were calculated by comparison with standard curves obtained with known concentrations of NP-specific monoclonal antibodies. (D-E) Concentrations of NP-specific IgM (D) or IgG1 (E) determined by ELISA in the sera of QM-TACI-wt or QM-TACI-ko mice after immunization with 100 μg NP-OVA. TACI deficiency decreased NP-specific IgM production and accelerated the production of NP-specific IgG. Concentrations were calculated by comparison with standard curves obtained with known concentrations of NP-specific monoclonal antibodies. Each dot represents results obtained from one mouse. Averages were compared by t test. Significant differences are noted: *P < .05; **P < .01. Shoichiro Tsuji et al. Blood 2011;118:5832-5839 ©2011 by American Society of Hematology

TACI deficiency does not impair B-cell activation and germinal center formation. TACI deficiency does not impair B-cell activation and germinal center formation. (A) The proportion of NP-specific B cells (idiotype-positive) in the spleen of QM-TACI-wt or QM-TACI-ko mice was analyzed by flow cytometry in mice immunized 10 days earlier. Splenocytes were stained with an anti–idiotypic antibody10 and with an anti–IgMa antibody that detects the allotype produced by the heavy chain-targeted allele. (B) Average proportions (above) or average number (below) of idiotype-positive cells obtained from 3 QM-TACI-wt or 3 QM-TACI-ko mice. Averages were compared by t test. Significant differences: *P < .05; **P < .01. (C) TACI deficiency does not decrease B-cell activation after immunization. Splenocytes were obtained from QM-TACI-wt or QM-TACI-ko mice immunized with 100 μg NP-OVA 10 days earlier. Splenocytes were stained with anti-CD19 and CD69 antibodies and analyzed by FACS. Activated B cells (CD19+, CD69+) were as frequent in TACI-proficient as in TACI-deficient mice. Average proportions of CD19+, CD69+ cells obtained from 3 QM-TACI-wt, or 3 QM-TACI-ko mice. Averages were compared by t test. Differences between groups were not significant. (D) TACI deficiency caused increases in size and number of germinal centers 10 days after immunization. Frozen sections of Peyer patches were stained with anti–GL7 antibody (brown), which specifically labels germinal center B cells. The figure is representative of 3 independent experiments. Digital images were obtained by Leica DM6000 B microscope (Leica) and with QCapture Pro Version 6.0.0 software (QImaging). Shoichiro Tsuji et al. Blood 2011;118:5832-5839 ©2011 by American Society of Hematology

TACI is required for differentiation of B cells into ASCs TACI is required for differentiation of B cells into ASCs. TACI-ko animals had decreased NP-specific IgM ASCs or NP-specific IgG ASCs compared with wild-type. TACI is required for differentiation of B cells into ASCs. TACI-ko animals had decreased NP-specific IgM ASCs or NP-specific IgG ASCs compared with wild-type. ASCs were enumerated in B cells isolated from the spleen (A-B) or in bone marrow cell suspensions (C-D) of C57BL/6-wt or C57BL/6-TACI-ko 21 days after immunization, by ELISPOT. Below the graphs, the diagrams show the ELISPOT wells from which the ASCs were enumerated and plated with 106, 5 × 105, or 105 cells, as indicated. Values were compared by t test. Significant differences: *P < .05; **P < .01. Data resulted from the analyses of 5 wild-type mice and 4 TACI-ko mice. Shoichiro Tsuji et al. Blood 2011;118:5832-5839 ©2011 by American Society of Hematology

TACI deficiency decreases production of ASCs in a B cell–autonomous manner. TACI deficiency decreases production of ASCs in a B cell–autonomous manner. (A-B) The number of ASCs was restored by adoptive transfer of TACI-wt B cells but not by transfer of TACI-wt T cells into TACI-deficient recipients. NP-specific IgM (A) or NP-specific IgG (B) ASCs were enumerated by ELISPOT of splenocytes 14 days after immunization, and after reconstitution by adoptive transfer of QM-TACI-wt or QM-TACI-ko B cells, and C57BL/6-wt or C57BL/6-TACI-ko T cells. Representative pictures of the ELISPOT wells are shown below each graph. Transfer efficiency was equivalent in all experiments and determined by enumerating IgMa-positive donor B cells by FACS analysis in the spleen of recipients at the time of analysis. The number of IgM-secreting cells was significantly decreased whenever reconstitution was done with TACI-ko B cells: *P = .016 (2-way ANOVA). The number of IgG-secreting cells in animals reconstituted with TACI-ko B cells and TACI-wt T cells was significantly decreased compared with animals reconstituted with TACI-wt B and T cells: *P = .041 (t test). Data resulted from analysis of 3 recipient mice for each type of transfer. Shoichiro Tsuji et al. Blood 2011;118:5832-5839 ©2011 by American Society of Hematology

TACI is necessary and sufficient to induce Blimp-1 in B cells. TACI is necessary and sufficient to induce Blimp-1 in B cells. (A-B) TACI deficiency abrogates Blimp-1 expression by B cells 14 days after immunization. Blimp-1 mRNA expression was detected by RT-PCR (A) and quantified by real-time PCR (B). Relative expression of Blimp-1 was calculated by determining the ratio of Blimp-1/β-actin in immunized B cells compared with the Blimp-1/β-actin ratio in B cells from nonimmunized mice. Results represent the mean ± SEM of 3 measurements/mouse of each of 4 mice/genotype. Values were compared by t test and found to be significantly different: ***P < .0001. (C-D) Expression of TACI is sufficient to induce Blimp-1. The 18.81 B cells were transfected with a vector encoding TACI and EGFP from a single bicistronic mRNA or with a control vector encoding only EGFP. RNA was isolated from sorted GFP-positive transfected cells, 24 hours after transfection and converted to cDNA. Blimp-1 mRNA expression was studied by RT-PCR, after 30 PCR cycles (C) or quantitative RT-PCR (D). Blimp-1 expression by 18.81 B cells expressing TACI was calculated relative to the Blimp-1 expression by 18.81 cells transfected with a GFP control vector. Results represent mean ± SEM of 3 separate measurements. Values were compared by t test and found to be significantly different: *P = .0103. (E) Blimp-1 and TACI expression decreased and BCL-6 expression increased with time in 18.81 B cells transfected with a TACI expression vector. The 18.81 B cells transfected with TACI and EGFP or with EGFP control vectors were cultured up to 3 days with or without 100 ng/mL APRIL, as indicated. TACI, BCL-6, and Blimp-1 mRNA expression was studied by RT-PCR, after 30 PCR cycles. Cells were collected at 0, 24, 48, and 72 hours in culture. Results are representative of 3 independent experiments. Shoichiro Tsuji et al. Blood 2011;118:5832-5839 ©2011 by American Society of Hematology

Ionizing radiation induces Blimp-1 expression independently of TACI Ionizing radiation induces Blimp-1 expression independently of TACI. (A-B) X-ray irradiation of 18.81 cells (A) or C57BL/6-TACI-ko cells (B) induces γH2AX foci, indicating accumulation of DNA double-strand breaks. Ionizing radiation induces Blimp-1 expression independently of TACI. (A-B) X-ray irradiation of 18.81 cells (A) or C57BL/6-TACI-ko cells (B) induces γH2AX foci, indicating accumulation of DNA double-strand breaks. Cytospin slides of nonirradiated (0 Gy) or irradiated (4 Gy) cells were stained with an anti-γH2AX antibody (top diagrams) and counterstained with 4,6-diamidino-2-phenylindole (bottom diagrams). (C) Irradiation of 18.81 B cells with 1 Gy or 4 Gy induces Blimp-1 expression transiently, detected by quantitative RT-PCR. Relative expression of Blimp-1 was calculated by determining the ratio Blimp-1/β-actin for each sample. Values reflect 3 independent measurements. (D) Irradiation induces Blimp-1 expression independently of TACI. TACI-ko B cells, isolated from C57BL/6-TACI-ko mice, were irradiated with 4 Gy and cultured with 15 μg/mL of LPS for 24 hours. Blimp-1 expression increased after irradiation of TACI-deficient B cells. RNA was obtained after 24 hours in culture and expression of Blimp-1 or β-actin analyzed by quantitative RT-PCR. Relative expression of Blimp-1 was calculated by determining the ratio Blimp-1/β-actin for each sample. Values reflect 3 independent measurements. Averages were compared by t test. Significant differences were noted: *P < .05, **P < .01, and ***P < .001. Shoichiro Tsuji et al. Blood 2011;118:5832-5839 ©2011 by American Society of Hematology